Sam Milliken

1.1k total citations
31 papers, 576 citations indexed

About

Sam Milliken is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Sam Milliken has authored 31 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Hematology. Recurrent topics in Sam Milliken's work include Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Sam Milliken is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Sam Milliken collaborates with scholars based in Australia, United Kingdom and United States. Sam Milliken's co-authors include Jennifer Turner, Ann M. Hughes, Bruce K. Armstrong, Anne Kricker, John Kaldor, Lin Fritschi, Geza Benke, Claire M. Vajdic, R Powles and Andrew E. Grulich and has published in prestigious journals such as The Lancet, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Sam Milliken

29 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sam Milliken Australia 12 218 158 116 90 75 31 576
D D Weisenburger United States 12 215 1.0× 194 1.2× 73 0.6× 48 0.5× 32 0.4× 16 452
Tommasina Perrone Italy 14 245 1.1× 183 1.2× 154 1.3× 186 2.1× 57 0.8× 41 562
Emel Ünal Türkiye 12 101 0.5× 148 0.9× 69 0.6× 31 0.3× 49 0.7× 60 471
Aggeliki Kοlialexi Greece 19 92 0.4× 94 0.6× 200 1.7× 59 0.7× 99 1.3× 47 1.1k
Jason Kolfenbach United States 9 93 0.4× 62 0.4× 134 1.2× 90 1.0× 57 0.8× 31 825
Jesús Fernández‐Herrera Spain 18 249 1.1× 164 1.0× 167 1.4× 160 1.8× 356 4.7× 69 989
Kazuyoshi Kajimoto Japan 13 162 0.7× 152 1.0× 80 0.7× 70 0.8× 25 0.3× 45 488
Sumie Tabata Japan 13 141 0.6× 137 0.9× 113 1.0× 101 1.1× 41 0.5× 49 449
Gizelle Popradi Canada 13 71 0.3× 196 1.2× 161 1.4× 401 4.5× 95 1.3× 29 638
Tomoaki Fujisaki Japan 16 168 0.8× 353 2.2× 219 1.9× 443 4.9× 94 1.3× 63 922

Countries citing papers authored by Sam Milliken

Since Specialization
Citations

This map shows the geographic impact of Sam Milliken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Milliken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Milliken more than expected).

Fields of papers citing papers by Sam Milliken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Milliken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Milliken. The network helps show where Sam Milliken may publish in the future.

Co-authorship network of co-authors of Sam Milliken

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Milliken. A scholar is included among the top collaborators of Sam Milliken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Milliken. Sam Milliken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polizzotto, Mark N., Sam Milliken, Tara Cochrane, et al.. (2023). Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance. British Journal of Haematology. 201(5). 865–873. 4 indexed citations
2.
Chadwick, Verity, Catherine Tang, Mary Ann Anderson, et al.. (2023). Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility. The Lancet Haematology. 10(6). e458–e467. 6 indexed citations
3.
Milliken, Sam, et al.. (2022). Potential intravenous immunoglobulin-induced optic disc edema. American Journal of Ophthalmology Case Reports. 27. 101617–101617.
4.
Tang, Catherine, Verity Chadwick, Barbara Withers, et al.. (2021). Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage. Blood. 138(Supplement 1). 3050–3050. 1 indexed citations
5.
Spencer, Andrew, Peter Browett, Frank Alvaro, et al.. (2020). High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission. Bone Marrow Transplantation. 55(11). 2207–2210.
6.
Morrissey, C. Orla, Danny Liew, Megan Bohensky, et al.. (2016). Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?. Medical Mycology. 55(7). myw141–myw141. 8 indexed citations
7.
Milliken, Sam, et al.. (2014). Adrenal tumours: how to establish malignancy. BMJ Case Reports. 2014. bcr2014203736–bcr2014203736. 2 indexed citations
8.
9.
10.
Bai, Lijun, Yi‐Mo Deng, Anthony J. Dodds, et al.. (2006). A SYBR green‐based real‐time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients. European Journal Of Haematology. 77(5). 425–431. 18 indexed citations
11.
Vajdic, Claire M., Andrew E. Grulich, John Kaldor, et al.. (2006). Specific Infections, Infection-Related Behavior, and Risk of Non-Hodgkin Lymphoma in Adults. Cancer Epidemiology Biomarkers & Prevention. 15(6). 1102–1108. 11 indexed citations
12.
Vajdic, Claire M., John Kaldor, Ann M. Hughes, et al.. (2005). Birth Order, Atopy, and Risk of Non-Hodgkin Lymphoma. JNCI Journal of the National Cancer Institute. 97(8). 587–594. 64 indexed citations
13.
Hughes, Ann M., Bruce K. Armstrong, Claire M. Vajdic, et al.. (2004). Pigmentary characteristics, sun sensitivity and non‐Hodgkin lymphoma. International Journal of Cancer. 110(3). 429–434. 38 indexed citations
14.
Hughes, Ann M., Bruce K. Armstrong, Claire M. Vajdic, et al.. (2004). Sun exposure may protect against non‐Hodgkin lymphoma: A case‐control study. International Journal of Cancer. 112(5). 865–871. 121 indexed citations
15.
Moore, John J., Peter Brooks, Sam Milliken, et al.. (2002). A pilot randomized trial comparing CD34‐selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis & Rheumatism. 46(9). 2301–2309. 125 indexed citations
16.
Turner, Jennifer & Sam Milliken. (2000). A case of keratin-positive acute myeloid leukemia: a possible role for cytokeratin 19 as a specific epithelial marker. Pathology. 32(2). 98–101. 10 indexed citations
17.
Malouf, M.A., et al.. (2000). Successful management of profound thrombocytopenia after lung and heart–lung transplantation. The Journal of Heart and Lung Transplantation. 19(6). 612–614. 2 indexed citations
18.
Milliken, Sam & R Powles. (1990). Antifungal Prophylaxis in Bone Marrow Transplantation. Clinical Infectious Diseases. 12(Supplement_3). S374–S379. 42 indexed citations
19.
Powles, R, PM Parikh, C. Smith, et al.. (1990). Bone-marrow transplant from father to son and subsequent graft from son to father. The Lancet. 335(8696). 999–1000. 4 indexed citations
20.
Ettinger, Neil, Peter J. Selby, R Powles, et al.. (1989). Cytomegalovirus pneumonia: the use of ganciclovir in marrow transplant recipients. Journal of Antimicrobial Chemotherapy. 24(1). 53–62. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D D Weisenburger Breakdown of academic impact, for papers by Tommasina Perrone Breakdown of academic impact, for papers by Emel Ünal Breakdown of academic impact, for papers by Aggeliki Kοlialexi Breakdown of academic impact, for papers by Jason Kolfenbach Breakdown of academic impact, for papers by Jesús Fernández‐Herrera Breakdown of academic impact, for papers by Kazuyoshi Kajimoto Breakdown of academic impact, for papers by Sumie Tabata Breakdown of academic impact, for papers by Gizelle Popradi Breakdown of academic impact, for papers by Tomoaki Fujisaki
Rankless by CCL
2026